pioglitazone has been researched along with Dermatoses in 3 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pioglitazone (PGZ) is a peroxisome proliferator-activated receptor agonist." | 1.51 | Nanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases. ( Calpena, AC; Clares, B; Espinoza, LC; Fábrega, MJ; Garduño-Ramírez, ML; Rodríguez-Lagunas, MJ; Silva-Abreu, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, D | 1 |
| Li, H | 1 |
| Zhou, R | 1 |
| Liu, MJ | 1 |
| Yu, H | 1 |
| Wu, DF | 1 |
| Espinoza, LC | 1 |
| Silva-Abreu, M | 1 |
| Calpena, AC | 1 |
| Rodríguez-Lagunas, MJ | 1 |
| Fábrega, MJ | 1 |
| Garduño-Ramírez, ML | 1 |
| Clares, B | 1 |
| O'Leary, R | 1 |
| Ponnambalam, S | 1 |
| Wood, EJ | 1 |
3 other studies available for pioglitazone and Dermatoses
| Article | Year |
|---|---|
Pioglitazone attenuates aging-related disorders in aged apolipoprotein E deficient mice.
Topics: Age Factors; Aging; Animals; Anti-Inflammatory Agents; Antioxidants; Aortic Diseases; Atherosclerosi | 2018 |
Nanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases.
Topics: Adult; Animals; Anti-Inflammatory Agents; Cytokines; Drug Liberation; Emulsions; Female; Humans; Inf | 2019 |
Pioglitazone-induced myofibroblast cell death: implications for cutaneous scarring.
Topics: Cell Death; Cell Survival; Cells, Cultured; Cicatrix; Fibroblasts; Humans; Hypoglycemic Agents; Musc | 2003 |